Ken Fisher Astrazeneca PLC Transaction History
Fisher Asset Management, LLC
- $271 Billion
- Q3 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Astrazeneca PLC stock. As of the latest transaction made, Fisher Asset Management, LLC holds 21,162,724 shares of AZN stock, worth $1.89 Billion. This represents 0.6% of its overall portfolio holdings.
Number of Shares
21,162,724
Previous 20,695,979
2.26%
Holding current value
$1.89 Billion
Previous $1.45 Billion
12.26%
% of portfolio
0.6%
Previous 0.58%
Shares
37 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...